Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction

The New England Journal of Medicine
F Van de WerfB E Sobel

Abstract

Tissue-type plasminogen activator is a naturally occurring, clot-selective activator of fibrinolysis. We recently reported that human tissue-type plasminogen activator isolated from a Bowes-melanoma-tissue-culture supernate lysed coronary thrombi in dogs without depleting circulating fibrinogen or alpha 2-antiplasmin, in contrast to the case with streptokinase and urokinase. In the present study coronary thrombolysis, confirmed angiographically, was induced within 19 to 50 minutes with intravenous or intracoronary tissue-type plasminogen activator in six of seven patients with evolving myocardial infarction. Circulating fibrinogen, plasminogen, and alpha 2-antiplasmin were not depleted by this agent, in contrast to the case in the two patients subsequently given streptokinase. In the one patient in whom lysis was not inducible with tissue-type plasminogen activator, it was also not inducible with streptokinase. These observations indicate that clot-selective coronary thrombolysis can be induced in patients with evolving myocardial infarction by means of tissue-type plasminogen activator, without concomitant induction of a systemic lytic state. Definition of its therapeutic benefit must await greater availability of the agent an...Continue Reading

References

Jul 1, 1969·Proceedings of the Society for Experimental Biology and Medicine·C MerskeyA J Johnson
Jun 2, 1983·The New England Journal of Medicine·J L AndersonA D Hagan
Aug 1, 1983·Circulation·D Collen, M Verstraete
Jan 1, 1982·The American Journal of Medicine·B E Sobel, S R Bergmann
Oct 1, 1981·The New England Journal of Medicine·J E MarkisE Braunwald
Oct 16, 1980·The New England Journal of Medicine·M A DeWoodH T Lang

❮ Previous
Next ❯

Citations

Jan 1, 1990·Journal of Clinical Laboratory Analysis·H MoscosoF A Garver
Oct 1, 1994·Annals of Hematology·D C Gulba, R Dechend
Jan 1, 1986·Cardiovascular and Interventional Radiology·W Rutsch, H Schmutzler
Jan 1, 1986·Cardiovascular and Interventional Radiology·K L Neuhaus
May 11, 2010·Applied Biochemistry and Biotechnology·Keivan Majidzadeh-AFereidoun Mahboudi
Mar 15, 1989·Thrombosis Research·J Ljungberg, U Hedner
Oct 1, 1989·Journal of the American College of Cardiology·B E Sobel
Nov 15, 1991·Journal of the American College of Cardiology·S Sherry, V J Marder
Oct 18, 1986·Lancet·S Z GoldhaberG V Sharma
Sep 18, 1998·Emergency Medicine Clinics of North America·O W Hayes
Aug 23, 2003·Journal of the American College of Cardiology·Harold L Dauerman, Burton E Sobel
Jan 1, 1985·Journal of the American College of Cardiology·E J TopolB H Bulkley
Dec 1, 1986·Journal of the American College of Cardiology·M Verstraete, D Collen
Jul 1, 1986·Journal of the American College of Cardiology·A S Jaffe
Apr 1, 1986·Journal of the American College of Cardiology·M L SimoonsA van der Laarse
Nov 1, 1986·Journal of the American College of Cardiology·B E Sobel
Nov 1, 1987·Journal of the American College of Cardiology·B E Sobel
Jun 7, 1984·The New England Journal of Medicine·G Robbins
Sep 13, 1984·The New England Journal of Medicine·G L Laffel, E Braunwald
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·B E SobelS J Sarnoff
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G BuA L Schwartz
Aug 19, 2010·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Nethnapha ParedesAnthony K C Chan
Feb 1, 1991·Acta Paediatrica Japonica; Overseas Edition·H KatoN Sato
Jun 8, 1985·British Medical Journal·L Poller
Nov 1, 1988·The Journal of Clinical Investigation·J I WeitzT Eckhardt
Mar 1, 1991·The Journal of Clinical Investigation·J I WeitzJ Ginsberg
Mar 21, 2001·Biological & Pharmaceutical Bulletin·S AokiY Tanigawara
Apr 2, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Takuji ToyamaKoichi Taniguchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.